🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07747623
Recruiting Not applicable

One-level and Bi-level ESPB Application in Patients Undergoing Breast Surgery

NCT07747623 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-09-11
Last updated
2026-09-15

Condition(s) studied

Pain, PostoperativeBreast SurgeryErector Spinae Plane BlockMultimodal Analgesia

Investigational drug(s) / intervention(s)

One-level Erector Spinae Plane BlockBi-level Erector Spinae Plane Block

One-level Erector Spinae Plane Block: One-level Erector Spinae Plane Block will be performed unilaterally, under US guidance, before the surgical operation, and when the patient is placed in the lateral decubitus position. In applications, 30 ml of 0.25% bupivacaine will be injected at the T3 level.

Bi-level Erector Spinae Plane Block: Bi-level Erector Spinae Plane Block will be performed unilaterally, under US guidance, before the surgical operation, and when the patient is placed in the lateral decubitus position. In applications, 15 ml of 0.25% bupivacaine at T2 level and 15 ml of 0.25% bupivacaine at T4 level will be injected.

Study summary

Acute pain after breast surgery can significantly reduce the quality of life for patients. If acute pain is not adequately treated, it can develop into chronic pain. Thoracic epidural analgesia, thoracic paravertebral block, erector spinae plane block, and serratus anterior plane block are frequently applied blocks. However, ESPB, being a fascial plane block, can yield inconsistent results regarding distribution and dermatomal area. In recent years, there has been an increase in publications applying ESPB from two levels to achieve wider distribution. As a result, this study aims to compare the analgesic efficacy of single-level (Thoracic 3) and two-level (Thoracic 2, Thoracic 4) ESPB applications.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 80 years * American Society of Anesthesiologists physical status I-II-III * Body mass index between 18 and 30 kg/m² * Patients undergoing elective breast surgery Exclusion Criteria: * Patient refusing the procedure * History of chronic analgesic or opioid therapy * History of local anesthetic allergy * Infection in the intervention area

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Etlik City Hospital Yenimahalle Ankara Recruiting

More Atatürk Chest Diseases and Chest Surgery Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07747623 on ClinicalTrials.gov ↗ ← All trials in Turkey